Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy

Goldstein, 2001, Familial hypercholesterolemia, 2863 Soutar, 2007, Mechanisms of disease: genetic causes of familial hypercholesterolemia, Nat Clin Pract Cardiovasc Med, 4, 214, 10.1038/ncpcardio0836 Williams, 1993, Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics, Am J Cardiol, 72, 171, 10.1016/0002-9149(93)90155-6 National Collaborating Centre for Primary Care, 2008 World Health Organization Familial hypercholesterolaemia (FH). Report of a second WHO consultation. Geneva: World Health Organization/WHO/HGN/FH/CONS/99.2; 1999. Varret, 2008, Genetic heterogeneity of autosomal dominant hypercholesterolemia, Clin Genet, 73, 1, 10.1111/j.1399-0004.2007.00915.x Marduel, 2010, Molecular spectrum of autosomal dominant hypercholesterolemia in France, Hum Mutat, 31, E1811, 10.1002/humu.21348 Palacios, 2012, Molecular characterization of familial hypercholesterolemia in Spain, Atherosclerosis, 221, 137, 10.1016/j.atherosclerosis.2011.12.021 Leigh, 2008, Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database, Ann Hum Genet, 72, 485, 10.1111/j.1469-1809.2008.00436.x Usifo, 2012, Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment, Ann Hum Genet, 76, 387, 10.1111/j.1469-1809.2012.00724.x Liyanage, 2011, Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution, Crit Rev Clin Lab Sci, 48, 1, 10.3109/10408363.2011.565585 Abifadel, 2009, Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease, Hum Mutat, 30, 520, 10.1002/humu.20882 Gotto, 1984, Recommendations for treatment of hyperlipidemia in adults, Circulation, 69, 1065A Cook, 2009, Growth curves for cardio-metabolic risk factors in children and adolescents, J Pediatr, 155, e15, 10.1016/j.jpeds.2009.04.051 Haase, 2012, Identification of people with heterozygous familial hypercholesterolemia, Curr Opin Lipidol, 23, 282, 10.1097/MOL.0b013e3283556c33 Deiana, 2000, Influence of ß°-thalassemia on the phenotypic expression of heterozygous Familial Hypercholesterolemia (FH): a study of FH patients from Sardinia, Arterioscler Thromb Vasc Biol, 20, 236, 10.1161/01.ATV.20.1.236 Bertolini, 2004, Genetic polymorphisms affecting the phenotypic expression in familial hypercholesterolemia, Atherosclerosis, 174, 57, 10.1016/j.atherosclerosis.2003.12.037 Bertolini, 2000, Clinical Expression of Familial Hypercholesterolemia in clusters of mutations of LDL-receptor gene causing receptor-defective or receptor-negative phenotype, Arterioscler Thromb Vasc Biol, 20, e41, 10.1161/01.ATV.20.9.e41 Bertolini, 1999, Analysis of LDL receptor gene mutations in Italian patients with homozygous Familial Hypercholesterolemia, Arterioscler Thromb Vasc Biol, 19, 408, 10.1161/01.ATV.19.2.408 Pisciotta, 2006, Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia, Atherosclerosis, 186, 433, 10.1016/j.atherosclerosis.2005.08.015 Rabacchi, 2009, An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia, Clin Chim Acta, 406, 75, 10.1016/j.cca.2009.05.017 Fasano, 2009, Degradation of LDLR protein mediated by ‘gain of function’ PCSK9 mutants in normal and ARH cells, Atherosclerosis, 203, 166, 10.1016/j.atherosclerosis.2008.10.027 Hegele, 2006, Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia, Genome, 49, 1343, 10.1139/g06-147 Tosi, 2007, Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic, Atherosclerosis, 194, 102, 10.1016/j.atherosclerosis.2006.10.003 Kusters, 2011, Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes, Neth Heart J, 19, 175, 10.1007/s12471-011-0076-6 Bourbon, 2008, Familial hypercholesterolaemia in Portugal, Atherosclerosis, 196, 633, 10.1016/j.atherosclerosis.2007.07.019 Cotton, 1998, Proof of “disease causing” mutation, Hum Mutat, 12, 1, 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M Fouchier, 2005, Update of the molecular basis of familial hypercholesterolemia in The Netherlands, Hum Mutat, 26, 550, 10.1002/humu.20256 Van der Graaf, 2011, Molecular basis of autosomal dominant hypercholesterolemia. Assessment in a large cohort of hypercholesterlemic children, Circulation, 123, 1167, 10.1161/CIRCULATIONAHA.110.979450 Humphries, 2006, Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk, J Med Genet, 43, 943, 10.1136/jmg.2006.038356 Junyent, 2010, Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia, Atherosclerosis, 208, 437, 10.1016/j.atherosclerosis.2009.07.058